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Abstract
Idiopath pulmonary ﬁbrosis (IPF) is a usually fatal disease asso-
ciated with hardening of the lung tissue, epithelial injury and abnor-
mal wound healing. Myoﬁbroblasts are cells with smooth muscle like
features and are believed to promote abnormal extracellular matrix
(ECM) deposition, perpetuated scarring and loss of tissue function
during ﬁbrosis. These cells seem to arise either from epithelial cells
via transforming growth factor (TGF훽1) induced epithelial to mes-
enchymal transition (EMT) or from the activation of resident ﬁbrob-
lasts through TGF훽1 mediated ﬁbroblast to myoﬁbroblast transition
(FMT). We treated with TGF훽1 three human lung epithelial cell lines
(H441, A549, H1975) and primary lung ﬁbroblasts from three healthy
patients and from three IPF patients. We used immunoﬂuorescence
techniques in order to quantify the expression of various cytoskeletal
proteins (F-actin, alpha smooth muscle actin and vimentin) in both
treated and untreated cells. We also used atomic force microscopy to
measure the Young modulus of the cells. When treated with TGF훽1,
epithelial cells adopted a mesenchymal morphology and displayed indi-
cators of EMT. TGF훽1 stimulated ﬁbroblasts acquired a myoﬁbroblast
phenotype, supporting the hypothesis of resident ﬁbroblast activation
through TGF훽1 induced FMT.
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1 Introduction
1.1 Idiopathic pulmonary ﬁbrosis (IPF)
Lung ﬁbrosis has been extensively studied and classiﬁed. Usually, lung ﬁ-
brosis is induced by traumatic injuries or by toxic or infectious agents, but
in some cases (IPF) ﬁbrosis appears without the presence of any obvious
external agent [1].
IPF is a form of chronic ﬁbrosing interstitial pneumonia, usually
fatal and untreatable, which is found in patients between 50 and 70 years
of age at presentation [2]. IPF prevalence ranges from 3-6 cases per 100000
in the UK up to 16-18 cases per 100000 in Finland and depends on loca-
tion, identifying criteria and year of study [3]. Pathologically, this disease
presents unique micro environmental alterations including alveolar epithelial
injury, disappearance of the basement membrane, ﬁbroblasts and myoﬁbrob-
lasts over accumulation [4]. This leads to the hardening of the lung tissue,
extracellular matrix (ECM) remodeling and increase in several pro-ﬁbrotic
soluble factors including transforming growth factor TGF-훽 [1, 2, 5]. Hys-
tologically, advanced IPF is characterized by the presence of normal lung
tissue interspersed with ﬁbroblast foci (areas with a dense population of ﬁ-
broblasts and myoﬁbroblasts) and areas of honeycombing (their structure is
similar to a honeycomb) [2].
IPF exact causes are still to be determined, but the current hypoth-
esis is that it results from epithelial injury and abnormal wound healing.
1.2 Wound healing in the lung tissue
In normal physiological conditions our organism is perfectly capable to re-
pair even severe epithelial injury. When the skin is wounded, the epithelial
cells migrate into the injured area, proliferate and diﬀerentiate to recon-
stitute tissue continuity (re-epitelialization). Moreover, the injury of the
tissue causes the disruption of the blood ﬂow in order to redo the home-
ostasis and to create a provisional extracellular matrix. This is where the
repair process starts. The deposition of ECM together with ﬁbroblast pro-
liferation, angiogenesis and immune ﬂow generate a granulation tissue rich
in small vessels, myoﬁbroblasts, ﬁbroblasts and inﬂammatory cells. When
re-epithelialization is complete, the number of myoﬁbroblasts from the gran-
ulation tissue decreases signiﬁcantly due to apoptosis. Furthermore, the
provisional ECM is degraded and the granulation tissue evolves into a scar
[6].
In pathological conditions, the adequate re-epithelialization is ab-
sent due to a slow epithelial response and the expression of adhesion molecules
is altered. During abnormal wound healing, the signals responsible for my-
oﬁbroblasts apoptosis are absent or delayed. This anomaly helps myoﬁbrob-
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lasts to survive and to produce abundant ECM components, which induce
impaired re-epitelialization, perpetuated scarring or ﬁbrosis and ﬁnally loss
of tissue function [2]. In addition, abnormal wound healing is characterized
by the hardening of the lung tissue, which is a hallmark of IPF.
1.3 Myoﬁbroblasts in lung ﬁbrosis
Myoﬁbroblasts are activated ﬁbroblasts with smooth-muscle like features.
These cells are able to produce proteases that destroy the damaged tissue
and are also able to synthesize collagen I required to form the provisional ma-
trix. Moreover, myoﬁbroblasts produce stress ﬁbers rich in 훼-sma (smooth
muscle actin), which contribute to ECM contraction. Due to all these prop-
erties, they are very important factors in ECM reorganization and wound
contraction [6]. During tissue injury the request for myoﬁbroblasts is be-
lieved to be very high and there is evidence suggesting that the myoﬁbrob-
lasts arise from multiple sources. One source is the activation of the resident
ﬁbroblasts through ﬁbroblast to myoﬁbroblast transition (FMT) mediated
by TGF훽1 [7].
After tissue injury, ﬁbroblasts are activated, migrate to the dam-
aged tissue and start synthesizing ECM. Furthermore, ﬁbroblasts lose their
stress-shield provided by ECM in normal tissue and are forced to acquire
contractile stress ﬁbers. Tomasek et al. (2002) [6] made a classiﬁcation of
myoﬁbroblasts. They named the ones that only express stress ﬁbers and
no 훼-sma ”proto-myoﬁbroblasts” and the ones that express 훼-sma ”diﬀer-
entiated myoﬁbroblasts”. When the proto-myoﬁbroblasts are formed (due
to mechanical tension), they are stimulated to express 훼-sma and to turn
into diﬀerentiated myoﬁbroblasts (Figure 1) [6]. Clinical studies done both
in vivo and in vitro showed that TGF훽1 is the key factor in promoting
the formation of stress ﬁbers, focal adhesion and ﬁbronectin ﬁbrils, com-
ponents that characterize the diﬀerentiated myoﬁbroblasts. There is also
evidence that ﬁbroblasts treated with TGF훽1 express myoﬁbroblast mark-
ers and adopt morphological properties of myoﬁbroblasts [8, 10, 9].
Another possible source for myoﬁbroblasts are the epithelial cells.
Clinical studies suggested that myoﬁbroblasts arise from epithelial cells as a
result of TGF훽1 induced epithelial to mesenchymal transition (EMT) [11, 4].
In order to verify this hypothesis, Willis et al. [11] used one alveolar ep-
ithelial cell (AEC) line (AT2) and isolated alveolar epithelial type II cells,
which were treated with TGF-훽1 for up to 12 days. Using phase imaging
and indirect immunoﬂuorescence, Willis et al showed that cells grown with
TGFp1 had a ﬁbroblast-like morphology and were expressing a big amount
of 훼-sma ﬁbers compared to the untreated cells. Several studies demonstrate
that during kidney, liver and breast ﬁbrosis, TGF훽1 is the key regulator in
epithelial cells transdiﬀerentiation [12, 13, 14]. These ﬁndings have provided
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the motivation to continue the investigations regarding myoﬁbroblasts for-
mation during ﬁbrosis.
Figure 1: Model of the role of myoﬁbroblasts during the healing of an open
wound [6]. a) In normal tissue ﬁbroblasts are stress-shielded by the sur-
rounding ECM. When the tissue is injured, the wound is ﬁlled with ﬁbrin and
ﬁbroblasts are stimulated by TGF훽1 to invade this provisional matrix. b)
Collagen matrix is rearranging due to the forces exerted by migrating ﬁbrob-
lasts. The developing mechanical stress induces stress ﬁbers into ﬁbroblasts,
converting them into proto-myoﬁbroblasts. c) Proto-myoﬁbroblasts synthe-
size alpha smooth muscle actin and evolve into diﬀerentiated myoﬁbroblasts,
which produce collagen and other ECM components. This continuous loop
shortens the collagen matrix and closes the wound. d) In normal conditions,
after wound healing, myoﬁbroblasts disappear due to apoptosis. e) In patho-
logic conditions, myoﬁbroblasts survive and continue producing collagen and
remodeling the ECM.
1.4 Epithelial to mesenchymal transition (EMT)
Epithelial cells form monolayers and present apical-basal polarized regularly
spaced cell-cell junctions and adhesions between neighboring cells that hold
them together. This enables the movement of the whole sheet of cells and
prevents individual cells to migrate from the epithelial monolayer. Epithe-
lial cells are characterized by the expression of speciﬁc epithelial proteins
such as E-cadherin, 훾-catenin and cytokeratins. By contrast, mesenchymal
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cells have their leading edge polarized front-to-back, do not form uniform
structures, are able to move individually due to weak adhesion forces be-
tween them and posses resistivity to apoptosis . The proteins expressed in
mesenchymal cells are vimentin, ﬁbronectin, 훼-smooth muscle actin [15].
The transformation of epithelial cells into mesenchymal cells im-
plies changes in morphology, mobility, cellular architecture and adhesion
forces, but also induces modiﬁcations in phenotypic markers (resistance to
apoptotic signals, increased migratory capacity) [15]. During EMT the ep-
ithelial units disaggregate and the epithelia changes its shape in order to
move. Transition epithelium loses tight and adherens junctions, loses polar-
ity and cytokeratin intermediate ﬁlaments. The next step involves F-actin
stress ﬁbers rearranging and ﬁlopodia and lamelipodia expression. This al-
lows transitioning cells to disrupt basement membranes and to migrate in
ECM, a process involved in tumor invasiveness [16].
EMT represents a phenotypic conversion due to molecular repro-
gramming of epithelium with new biochemical instructions and the result
are cells that express both epithelial and mesenchymal markers.
1.5 Aims
The purpose of this thesis was to ﬁnd what cells are responsible for abnormal
tissue hardening: resident ﬁbroblast through FMT or epithelial cells through
EMT. In this sense, two diﬀerent experiments using two diﬀerent techniques
were conducted. In the ﬁrst experiment epithelial cells and ﬁbroblasts were
treated with TGF훽1 and the diﬀerences between the mechanical properties
(elasticity) of treated and untreated cells were studied using Atomic Force
Microscopy (AFM) measurements. This technique is standard and it was
successfully applied before for measuring the Young modulus of human alve-
olar and bronchial cells. In the second experiment immunoﬂuorescence was
used in order to check if TGF훽 treated cells achieve markers for EMT or
FMT.
2 Materials and methods
2.1 Cell culture
The study was performed with human primary lung ﬁbroblasts and lung
epithelial cell lines. Epithelial cell lines included: A549, H441 and H1975.
A549 were cultured in HEPES (Sigma Chemical, St. Luis, MO) medium,
buﬀered RPMI 1640 with 10% inactivated fetal calf serum (Biological Indus-
tries, Kibbutz Beit Haemek, Israel), 100 U/ml penicillin, 1mM L-glutamine,
100 mg/ml streptomycin (GIBCO, Gaithersburg , MD) and 2휇g/ml ampho-
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tericin B (Bristol-Myers Squibb Co, New Brunswick, NJ). H441 and H1975
were grown in RPMI 1640 with 10% fetal bovine serum (FBS) and 100휇M
penstreptomycin.
The ﬁbroblasts were provided by the Department of Interstitial
Cells, IDIBAPS, Barcelona, Spain. All the cells were incubated into a
temperature-controlled chamber at 37 ∘C in an atmosphere of 5% CO2. 5
days before the measurements, the cells were trypsinated and plated on 3
10-mm diameter glass cover slips, that were previously washed with ethanol
and acetone. After plating, the cells were kept 24h in RPMI 1640 medium
with 10% FBS and another 24 h in serum free RPMI 1640 medium. For the
next 72 h, one cover slip was maintained with RPMI 1640 medium with 0%
FBS and a second cover slip was kept with RPMI 1640 medium 0% FBS
and treated with TGF훽1.
2.2 Immunostaining
Cells were washed twice with PBS and ﬁxed with formaldehyde for 15 min-
utes, incubated with a primary antibody (mouse monoclonal anti alpha
smooth muscle actin, anti vimentin) diluted in 1% BSA-PBS at 37 ∘C for
1 hour. After washing 3 times with PBS, the corresponding secondary an-
tibody was added and incubated for 1 hour at 37 ∘C. Vimentin and alpha
smooth muscle actin were stained using secondary antibody conjugated with
ALEXA ﬂuor 488 (green). F-actin was stained using falloidin TRITS red.
DAPI was used to counterstain the nuclei and incubated for 5 minutes. The
samples were mounted with PROLONG GOLD medium and left to dry in
the dark.
2.3 Measurements
2.3.1 AFM
The physical properties of the cells were measured with a standalone atomic
force apparatus AFM (Bioscope, Veeco) mounted on the stage of an inverted
optical microscope (Axiovert S100,Zeiss, Gottingen, Germany). The inden-
tation of the cells was made using silicon nitride triangular cantilevers with
nominal spring constant k=0.03 N/m and cantilever length of 20휇m (Au
coated, Veeco). The cantilever had a regular four-sided pyramidal punch
with nominal semiincluded angle Θ=35 degrees. The values of the nominal
k and Θ served for data processing.
AFM measurements were carried out at a temperature of 37 ∘C.
The relationship between cantilever’s deﬂection and the photodiode signal
was calibrated before cell measurements with the cantilever in contact with a
bare region of the cultured glass cover slip. The sensor signals of the recorded
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position are in linear relationship with the photodiode. The slope represents
the calibration factor. The force F on the cantilever was computed using
Hooke’s law : F=k*d, where k is the nominal spring constant and d repre-
sents the deﬂection of the cantilever. This deﬂection was measured with a
laser spot focused on cantilever that is reﬂected oﬀ into a photodiode. The
elasticity of the cells was probed in the perinuclear region of the cell. For
every cell, 3 force-displacement curves (10 휇푚/푠; 5 휇m amplitude) with a
maximum force of approximately 4 nN were recorded.
2.3.2 Confocal microscopy
Immunoﬂuorescence images were captured with an inverted microscope sys-
tem Nikon eclipse Ti series (Nikon Instruments Inc, Melville, NY, USA) us-
ing the Metamorph software (Molecular Devices, Downingtown, PA, USA).
An automated protocol was developed for image acquisition. A 7 steps
routine was developed with the help of the Metamorph software and the
motorized stage of the Nikon eclipse Ti microscope in order to automate
image acquisition (Figure 2). First, in every sample it was chosen randomly
an initial point, which was registered on the stage as coordinate 0. Second,
at 7 non-overlapping locations, images were acquired manually using pre-
deﬁned time exposures. The images were exported to Image J (free software
from http://rsbweb.nih.gov/ij) as Tiﬀ ﬁles.
Figure 2: Illustration of the Metamorph routine used to acquire immunoﬂu-
orescence images. In the left image are presented the coordinates corre-
sponding to each location. In the right image is shown the distribution of
the 7 areas within the well. The locations were chosen randomly.
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2.4 Data processing
2.4.1 AFM data processing
The correction for the zero-force oﬀset was applied to the force exerted on
the cantilever. The force and the indentation of a four-sided pyramidal in-
denter are related by
퐹 = 3퐸푡푎푛휃
4(1−휈2)훿
2 [17]
E is the Young modulus and 휈 is Poisson’s ratio of the cell. The value of 휈
was assumed to be 0.5. 훿 represents the cell indentation depth and it was
calculated as 훿=z-푧푐-d.
In order to compute 푧푐., Eq. 1 is expressed in terms of z and d
푧 − 푑 = 푧푐 + (4(1−휈
2)푘푑
3퐸푡푎푛휃 )
1/2
E and 푧푐 were obtained as least-square ﬁtting parameters of Eq.2 to the
loading trace of the F-z curve measured on each cell [17].
2.4.2 Confocal image processing
In order to process the images, two protocols were developed: one was used
to calculate the average intensity of a protein (F-actin, alpha smooth muscle
actin or vimentin) and another one was used to calculate the fraction of cells
that are alpha smooth muscle actin positive within the population (Figure
6).
Average intensity calculation
In order to quantify the level of expression of a given protein, the
average intensity of immunoﬂuorescence images (Imean), which was calcu-
lated by dividing the total intensity of the image to the total number of
pixels in the image (Figure 3), was divided by the total number of nuclei
within that image. Moreover, this quantity was averaged for all the seven
images acquired in the same well and the result (퐼푎푣푒푟푎푔푒) was used to com-
pare the level of expression of a given protein in all the samples.
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Figure 3: Example of a stack analyzed using the Intensity vs Time plot
plugin of ImageJ processing tool. On the left side is showed a representative
image acquired in the well treated with TGF훽1 of a sample consisting from
ﬁbrotic ﬁbroblasts stained for vimentin. The window in the right is the
plot-window that shows the mean intensity corresponding to every image in
the stack.
To validate the protocol of Average Intensity Calculation, we mea-
sured the expression of vimentin in human lung ﬁbroblasts control and
treated with TGF훽1. The cytoskeletal protein was expected not to exhibit
any variation and it was used asa negative control. The results are shown
in Figure 4.
Figure 4: Fluorescence intensity of vimentin measured on human lung nor-
mal and ﬁbrotic ﬁbroblasts. Dark bars indicate the control samples (-
TGF훽1) and gray bars indicate the treated samples (+TGF훽1). *p<0.05
TGF훽1 treated cells vs control cells.
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Quantiﬁcation of activated cells fraction
The fraction of cells activated with alpha smooth muscle actin was
quantiﬁed by dividing the number of activated cells from one image (Na)
to the total number of cells (Nn) within that image. To ﬁnd the number
of activated cells, the intensity distribution histogram of the alpha smooth
muscle actin stained images was analyzed. Depending on the values ex-
pressed by the histogram, the same threshold was applied to every image in
order to maintain only the pixels with an intensity above a certain threshold
value (Figure 5). Images showing the nuclei were merged with alpha-smooth
muscle actin images that were processed as described above. Cell counting
was done manually by counting nuclei (Figure 6).
Figure 5: Quantiﬁcation of the percentage of activated nuclei with alpha
smooth muscle actin. The original image showing the expression of alpha-
smooth muscle actin was corrected for the background. Next, a threshold
for the intensity was applied and the images showing the nuclei and the
alpha smooth muscle actin were merged. The result is shown in the bottom
right corner.
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Figure 6: Illustration of the counting process using Cell Counter plugin.
Images were acquired in the well containing untreated ﬁbrotic ﬁbroblasts.
The image exposed is the ﬁfth in the stack and to analyze it, the Type 5
counter was used. The number of nuclei within this image is saved in the
box corresponding to this counter.
2.4.3 Statistical analysis
Signiﬁcance levels were calculated using Students t-test for unpaired sam-
ples. P<0.05 was considered signiﬁcant.
3 Results
TGF 훽1 induces EMT in human lung epithelial cells
During EMT epithelial cells suﬀer morphological modiﬁcations,
gain mobility and start expressing mesenchymal markers such as vimentin.
In order to verify if TGF훽1 induces EMT, two human lung epithelial cell
lines (A549 and H1975) were activated with TGF훽1 and stained for vi-
mentin. The results are shown in Figure 7. In contrast with the control
cells, treated cells expressed signiﬁcantly more vimentin and presented a
wider, spread-out morphology (Figures 8 and 9). Although normal epithe-
lial cells do not express vimentin, A549 and H1975 cells express it even if
not treated with TGF훽1, but in a very low amount compared to ﬁbroblasts
(data not shown). This is due to their carcinomic origin.
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Figure 7: Fluorescence intensity of vimentin measured in control cells (black
bars) and TGF훽1 treated cells (gray bars) of A549 and H1975 cell lines. **
p<0.01 ; * p<0.05 TGF훽1 treated cells vs control cells.
Figure 8: Fluorescence micrographs of A549 cells acquired with an objective
of 20x. a-d images were captured in a control (without added growth factor)
sample and e-h in a TGF훽1 treated sample. a and e represent phase images
of the cells, b and f show the level of F-actin (red), c and g the level of alpha
smooth muscle actin (green), d and e the level of vimentin (green). The
nuclei are shown in blue.
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Figure 9: Fluorescence micrographs of H1975 cells. The images were ac-
quired in both control (a-d) and treated (e-h) samples with a 20x objective.
a and e represent phase images of the cells, b and f show the level of F-actin
(red), c and g the level of alpha smooth muscle actin (green), d and e the
level of vimentin (green). The nuclei are shown in blue.
Treatment with TGF훽1 stimulates the increase in alpha
smooth muscle actin expression in human lung ﬁbroblasts
Alpha smooth muscle actin is commonly used as a marker for my-
oﬁbroblast phenotype. We found that control human lung ﬁbroblasts from
three diﬀerent patients suﬀered a signiﬁcant increment in the number of cells
activated with alpha smooth muscle actin when treated with TGF훽1 (Fgure
10). Moreover, they presented a more ﬁbrogenic appearance compared to
the untreated ﬁbroblasts (Figure 11). Fibrotic human lung ﬁbroblasts from
three diﬀerent patients were activated with TGF훽1 and in two cases the
number of activated cells with alpha smooth muscle actin was higher than
in ﬁbrotic ﬁbroblasts untreated (Figure 10). In the case of human lung
epithelial cells, the fraction of activated cells was very low (under 1%) and
stimulation with TGF훽1 did not change the number of alpha smooth muscle
actin activated cells (Figures 8 and 9, c and g).
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Figure 10: Percentage of cells activated with alpha smooth muscle actin
measured in human lung epithelial cells, control ﬁbroblasts and ﬁbrotic ﬁ-
broblasts. Dark bars show the samples control (-TGF훽1) and gray bars in-
dicate the samples treated with TGF훽1. *** p<0.005; ** p<0.01; * p<0.05
TGF훽1 treated cells vs control cells.
Figure 11: Fluorescence micrographs of healthy human lung ﬁbroblasts
(F169). The images were acquired in both control (a-c) and treated (d-
f) samples with a 20x objective. a and d represent phase images of the cells,
b and e show the level of F-actin (red), c and f the level of alpha smooth
muscle actin (green). The nuclei are shown in blue.
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Treatment with TGF훽1 leads to an increase in the stiﬀ-
ness of the lung cells
In Figure 12 is showed an example of representative deﬂection vs
z curves recorded in A549 cells. The left curve was measured on a control
cell and the right curve was measured on a cell treated with TGF훽1. The
behavior of H441 cells and ﬁbroblasts was similar. In the left region of the
contact point (indicated by the arrow) the cantilever was not in contact with
the cell and the approaching and the withdrawing forces were constant. In
the right region of the contact point the force is not linear because the tip
is indenting the cell. At low speed (10 휇m/s ) the hysteresis is caused by
the dissipation of the energy within the cell. The slope of the deﬂection-
displacement curve measured in the control cell (left image) is smoother
than the slope corresponding to the curve measured in the cell treated with
TGF훽1 (right image). This diﬀerence is an indicator that the cells become
stiﬀer after being treated with TGF훽1.
Figure 12: Illustration of the experimental process. The blue and the red
lines show the deﬂection-displacement curve recorded in the perinuclear re-
gion of the A549 cells. The deﬂection-z curves were measured while the
piezotranslator was extended (blue line) toward the cell and retracted (red
line) at constant velocity (10 휇m/s). The hysteresis of the curve is due to
the viscoelasticity of the cell. The black arrow indicates the contact point.
The values of the Young modulus measured in both control and
TGF훽1 treated cells are shown in Figure 13. It can be seen that in epithe-
lial cells and in ﬁbrotic ﬁbroblasts there is a signiﬁcant increase in Young
modulus values when TGF훽1 is added. In contrast, control ﬁbroblasts do
not show diﬀerences in stiﬀness when stimulated with this pro ﬁbrotic factor.
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Figure 13: Young modulus measured on control cells (black bars) and
TGF훽1 treated cells (gray bars). It is represented the mean value for control
and ﬁbrotic ﬁbroblasts. *** p<0.005 TGF훽1 treated cells vs control cells.
The inﬂuence of TGF훽1 on the expression of F-actin and
alpha smooth muscle actin
The level of expression of F-actin augmented signiﬁcantly in all
human lung epithelial cells treated with TGF훽1 (Figure 14). By contrast,
the expression of alpha smooth muscle actin did not change in treated epithe-
lial cells (Figure 15, right). Control ﬁbroblasts from two diﬀerent patients
expressed more F-actin when activated with TGF훽1 and the behavior of
treated ﬁbrotic ﬁbroblast was similar (Figure 14, right). Although it was
noticed an increase in the amount of F-actin in both control and ﬁbrotic
ﬁbroblasts stimulated with TGF훽1, in average the diﬀerence between con-
trol and treated samples was not signiﬁcant (Figure 14,left). Alpha smooth
muscle actin expression was much higher in all activated control ﬁbroblasts
and in two samples with treated ﬁbrotic ﬁbroblasts (Figures 15, right, and
16, c and g).
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Figure 14: Fluorescence intensity of F-actin measured in normal (black bars)
and TGF훽1 treated (gray bars) human lung epithelial cells, control and
ﬁbrotic ﬁbroblasts. The image on the left presents the average intensity
of F-actin for control and ﬁbrotic ﬁbroblasts. *** p<0.005; ** p<0.01; *
p<0.05 TGF훽1 treated cells vs control cells.
Figure 15: Levels of ﬂuorescence intensity of alpha smooth muscle actin
measured in human lung cells. Black bars indicate the control samples and
the gray bars indicate the TGF훽1 treated cells. The image on the right
shows the averaged values measured in ﬁbroblasts. *** p<0.005; ** p<0.01;
* p<0.05 TGF훽1 treated cells vs control cells.
17
Figure 16: Fluorescence micrographs of ﬁbrotic ﬁbroblasts acquired with an
objective of 20x. a-d images were captured in a control sample and e-h in a
TGF훽1 treated sample. a and e represent phase images of the cells, b and
f show the level of F-actin (red), c and g the level of alpha smooth muscle
actin (green), d and e the level of vimentin (green). The nuclei are shown
in blue.
4 Discussion
Myoﬁbroblasts are found in granulation tissue [6] and in areas with abnor-
mally high ECM expression [7] during pulmonary ﬁbrosis. These cells are
believed to be an important factor during epithelial injury and in promoting
ECM deposition, which can lead to tissue hardening and ﬁbrosis. Although
their origin is still unknown, myoﬁbroblasts may arise from resident ﬁbrob-
lasts via TGF훽1 induced FMT [6] or from epithelial cells through EMT
induced by the presence of TGF훽1 [18, 19].
We treated human lung epithelial cell lines and primary cultured
normal and ﬁbrotic ﬁbroblasts with TGF훽1 and we measured the Young
modulus (E) in both control and treated cells. E was obtained using the
least-squares ﬁtting estimation of the loading F-z curve recorded on each
cell. This estimation was used before to characterize the rheology of human
epithelial cells [17]. The mechanical behavior of all the untreated cells was
similar. By contrast, when stimulated with TGF훽1, cells acted very het-
erogeneously. While A549 cells and ﬁbrotic ﬁbroblasts exhibit a signiﬁcant
increase in stiﬀness, H441 and control ﬁbroblasts showed no noticeable dif-
ference between treated and untreated cells. This might be correlated with
the fact that A549 cells are originated from malignant tissue and ﬁbrotic
ﬁbroblasts from ﬁbrotic tissue. At cytological level, epithelial cells stimu-
lated with TGF훽1 showed a very high level of vimentin and F-actin and
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adopted a more mesenchymal morphology, all of them indicative of EMT.
However, the expression of alpha smooth muscle actin in A549 cells was not
signiﬁcant. This fact in addition to the increase in stiﬀness suggests that
TGF훽1 can induce EMT in human lung epithelial cells, but is not suﬃcient
to transform the epithelial cells into diﬀerentiated myoﬁbroblasts.
Diﬀerentiated myoﬁbroblasts are commonly characterized by the
presence of alpha smooth muscle actin. Previous studies showed that TGF훽1
induces alpha smooth muscle actin expression in rat and human breast ﬁ-
broblasts [20, 21]. Our results showed that TGF훽1 stimulates the increase
in the number of alpha smooth muscle actin activated cells in primary cul-
tured control and ﬁbrotic lung ﬁbroblasts, which supports the hypothesis of
TGF훽1 mediated FMT of resident ﬁbroblasts.
Although the increase in stiﬀness and the high levels of F-actin and
vimentin expressed by epithelial cells treated with TGF훽1 could be corre-
lated, this correlation was not observed in normal ﬁbroblasts. While the
expression of alpha smooth muscle actin and the number of cells activated
with this protein were much higher in treated control ﬁbroblasts than in
untreated ones, the level of F-actin and the stiﬀness were not changing sig-
niﬁcantly in the presence of TGF훽1. These ﬁndings strongly suggest that
proteins other than F-actin and alpha smooth muscle actin are involved
in the abnormal mechanical responses of control and ﬁbrotic ﬁbroblasts to
TGF훽1. Fibrotic ﬁbroblasts exhibited a diﬀerent behavior after treatment
with TGF훽1. They become much stiﬀer, albeit there was no major increase
in the levels of F-actin and alpha smooth muscle actin. This means that
stiﬀness increase is not caused by the apparition of stress and smooth muscle
ﬁbers.
Our results were very heterogeneous due to the usage of three diﬀer-
ent types of cells, with diﬀerent origins and to one experimental limitations.
This limitation was the calculation of the Young modulus for what we as-
sumed that the cell is an incompressible material (휈 = 0.5).
5 Conclusions
Atomic force microscopy was used to measure the Young modulus of human
lung epithelial cells and primary cultured normal and ﬁbrotic ﬁbroblasts. In
normal conditions all the cells revealed similar elastic behavior, but treated
with the pro-ﬁbrotic soluble factor TGF훽1 they exhibited a very heteroge-
neous response. Immunoﬂuorescence was used in order to follow the dif-
ferences in various cytoskeletal proteins between control and treated cells.
By correlating the results, it was seen that TGF훽1 induced morphological
and cytoskeletal changes in epithelial cells indicative of EMT, although this
was not suﬃcient to transform the epithelial cells in diﬀerentiated myoﬁ-
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broblasts. Moreover, TGF훽1 promoted the apparition of F-actin ﬁbers and
upregulated smooth muscle actin expression in normal ﬁbroblasts, which is
consistent with hypothesis that ﬁbroblast diﬀerentiate into myoﬁbroblasts
when treated with TGF훽1 (FMT). Activated with TGF훽1 ﬁbrotic ﬁbrob-
lasts become much stiﬀer, but did not achieve more F-actin or alpha smooth
muscle actin, probably because these cells are already transformed.
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